Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    11209178 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients
Condition: Botulism
Intervention: Biological: One 5 mL of blood will be collected.
2 Enrolling by invitation BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin
Condition: Botulism
Intervention:

Study has passed its completion date and status has not been verified in more than two years.